Zhongzhi Pharmaceutical Holdings Ltd 2024 AR2

The report highlights Zhongzhi Pharmaceutical Holdings Limited's performance for the fiscal year 2024, during which the Group's revenue rose by 8.0% to approximately RMB2,214.8 million, driven by the expansion of its traditional Chinese medicine decoction pieces business under the core brand Caojinghua. The modern proprietary Chinese medicine production park of Honeson Pharmaceutical was completed and put into operation, and the Shiqi Waigan Tea Cultural Museum was officially opened. On the sustainability front, the Group continued to promote standardized plantation bases for Chinese medicine herbs, with its Gansu Astragalus base passing the GAP compliance inspection. Additionally, the international standard for the ultrafine powder of herbs (ISO 6904), led by the company, was officially published in June 2024.

Company: Zhongzhi Pharmaceutical Holdings Ltd

Sector: Health Care

Country: China

Year: 2024

Type: AR2

Pages: 193

Back to company

Zhongzhi Pharmaceutical Holdings Ltd

Zhongzhi Pharmaceutical Holdings Ltd 2024 Annual Report

Annual Report

The report highlights Zhongzhi Pharmaceutical Holdings Limited's performance for the fiscal year 2024, during which the Group's revenue rose by 8.0% to approximately RMB2,214.8 million, driven by the expansion of its traditional Chinese medicine decoction pieces business under the core brand Caojinghua. The modern proprietary Chinese medicine production park of Honeson Pharmaceutical was completed and put into operation, and the Shiqi Waigan Tea Cultural Museum was officially opened. On the sustainability front, the Group continued to promote standardized plantation bases for Chinese medicine herbs, with its Gansu Astragalus base passing the GAP compliance inspection. Additionally, the international standard for the ultrafine powder of herbs (ISO 6904), led by the company, was officially published in June 2024.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Jan 1, 2024 - Dec 31, 2024

Fiscal Year

2024

Type

Annual Report with Sustainability Disclosures

Language

English

Pages

 

File Size

 

Standards & Assurance

Materiality Assessment

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Water Consumption

Workplace Fatalities

Employees